When I learned of the Food and Drug Administration’s approval of aducanumab (Aduhelm) for Alzheimer’s disease, I was struck by the parallels with the agency’s approval of tacrine (Cognex) in 1993, the ...
Review the side-effects of Tacrine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
This medication is a cholinesterase inhibitor, prescribed for mild to moderate dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results